Buy NM2201 for sale online from USA vendor
Discount program: 5% OFF for the second order, 7% OFF for the third order.
Shop with us securely! We offer re-shipment guarantees.
We always provide new, legal products of impeccable quality.
Please make sure that the product is legal in your country and not under any restrictions before ordering.
We do not sell pharmaceutical products or controlled substances.
What is NM-2201?
NM-2201, also known as CBL-2201, is a synthetic cannabinoid whose possible effects on the human body have received interest in recent years. This indole-based molecule shares comparable qualities with other synthetic cannabinoids, such as 5F-PB-22 and NNE1, which are full agonists that bind with low nanomolar affinity to both CB1 and CB2 receptors.
The History of NM-2201
The origins and development of NM-2201 are shrouded in mystery, with very little information accessible. It is thought to have initially arrived on the market in the early 2010s as part of a rising trend of synthetic cannabinoids designed to mimic the effects of cannabis without being caught in drug tests.
Since then, NM-2201 has been classed as a prohibited drug in many nations, including the United States, due to its abuse potential and propensity to cause harm to users. Despite this, it is sold on the illicit market, frequently as a "legal high" or "herbal incense."
The Chemical Structure of NM-2201
NM-2201 is a synthetic cannabinoid whose chemical structure is derived from indole. It is known that this structure produces psychotropic effects when administered to humans, and it is thought that NM-2201 functions via binding to cannabinoid receptors in the brain and central nervous system.
More study is required to thoroughly comprehend how NM-2201 interacts with the human body and its precise mechanisms of action. It is thought, however, that the molecule has a strong affinity for CB1 receptors, which are situated mainly in the brain and are responsible for the euphoric effects of cannabis.
The Effects of NM-2201
The effects of NM-2201 are highly variable based on the individual and the dose ingested. This synthetic cannabinoid has been associated with altered perception, mood changes, and an enhanced sensation of relaxation or pleasure. In certain situations, individuals have reported experiencing anxiety or paranoia; hallucinations or other cognitive distortions are also possible.
Given the lack of regulation and control over its manufacturing and distribution, it is crucial to stress that the effects of NM-2201 can be unexpected and harmful. Additionally, the substance's strength might vary substantially, with some batches possessing significantly greater concentrations of the active component. This can make it harder to manage the strength and duration of the effects, as well as raise the likelihood of overdosing or other harmful consequences.
To prepare the content, the following materials were used:
- FDA Substance Registration System
- Hazardous Substances Data Bank. National Library of Medicine. 28 August 2008. Retrieved 22 August 2014. 3,4-Methylenedioxymethamphetamine
- Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis. PDF . By HoChong Gilles, Scott C Matherly, Mohammed S Siddiqui, Puneet Puri...
- Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis . By Jasmohan Bajaj
- An overview of alcohol and other drug issues
- Medicating the mind: a Kantian analysis of overprescribing psychoactive drugs B A Manninen
- The pharmacological basis of opioids Carla Ghelardini, Lorenzo Di Cesare Mannelli and Enrica Bianchi
- Ask Dr. Shulgin Online ARCHIVE: June 3, 2004
- Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines. Nicholas V Cozzi, Michael KSievert, Alexander T Shulgin, Peyton JacobIII, Arnold Eruoho
- Schedules of Controlled Substances: Placement of Methylone Into Schedule I
- Bioanalysis of new designer drugs. Wohlfarth A, Weinmann W.
- New Psychoactive Substances (including synthetic cannabinoids, mephedrone, and more)
- Future Synthetic Drugs of Abuse. Donald A. Cooper. Drug Enforcement Administration McLean, Virginia
- Designer drugs: a medicinal chemistry perspective. F. Ivy Carroll Anita H. Lewin S. Wayne Mascarella Herbert H. Seltzman P. Anantha Reddy
- Synthetic cannabinoids in Europe
- Pharmacological Effects of MDMA in Man. By Enno Freye
- Drug Use in Relation to Outcome of Mammography Screening. von Euler-Chelpin M, Wu W, Vejborg and Lynge E
- DEA Drug Scheduling
- Electrophysiological Effects of Trace Amines on Mesencephalic Dopaminergic Neurons.Ada Ledonne, Nicola Berretta, Alessandro Davoli, Giada Ricciardo Rizzo, Giorgio Bernardi and Nicola Biagio Mercuri
- Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine-related drugs on rat midbrain dopaminergic neurons.Scarponi M, Bernardi G, Mercuri NB.
- Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management. Henry A. Spiller, author Hannah L. Hays Alfred Aleguas.
- Dose-dependent effectiveness of wheel running to attenuate cocaine-seeking: impact of sex and estrous cycle in rats. Peterson AB, Hivick DP, Lynch WJ.r.
- FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
- ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
- Controlled Substances Act
- The Art of Drug Synthesis (Wiley Series on Drug Synthesis)
- Cannabis: domestic cultivation widespread
- A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics